The table below shows TEVA PHARMACEUTICAL INDUSTRIES LTD's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Revenue
$3.98B
$1.50B
$4.48B
$4.18B
$3.89B
$4.33B
Cost of revenue
$2.01B
-
$2.18B
$2.07B
$2.01B
$2.18B
Gross profit
$1.97B
-
$2.30B
$2.10B
$1.88B
$2.15B
R&D
-
-
-
-
-
-
TEVA annual revenue (10-K history)
TEVA PHARMACEUTICAL INDUSTRIES LTD reported annual revenue of $17.26B for fiscal year 2025. That is up 4.3% from $16.54B in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $21.90B (FY 2016) to $17.26B. Figures come from the company's audited annual reports as filed with the SEC.
